万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/scie期刊 >>医药卫生>>内科学

Leukemia Research(研究方向:血液学) (官网投稿)

简介
  • 期刊简称待设置
  • 参考译名待设置
  • 核心类别 外文期刊,
  • IF影响因子待设置
  • 自引率待设置
  • 主要研究方向待设置

主要研究方向:

等待设置主要研究方向
待设置

Leukemia Research(月刊),创刊于1977年,出版国家为英国。Leukemia Research是一项国际杂志,为所有参与白血病,淋巴瘤,多发性骨髓瘤和其他血液恶性肿瘤的基础和(或)应用临床研究的保健专业人员提供全面和最新的信息。该编辑鼓励提交的有关正常和白血病造血,生物化学,细胞生物学,免疫学和分子生物学以及流行病学和临床研究的文章。
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊官网:

https://www.journals.elsevier.com/leukemia-research/

3、期刊投稿:

http://ees.elsevier.com/lr/tempdown.asp

4、官网电话:+91 44 4299 4784

5、信息说明:本刊信息来源于网络,包括 SCI 收录核心期刊,增补期刊,期刊收录数据每年进行更新。本站是公益性网站,为网友投稿提供免费服务,由于受相关约束,我们不能提供相关期刊的影响因子、JCR期刊分区等数据供大家参考,造成不便,敬请谅解。

2017427日星期四

                          

 

Author Guidelines

 

Leukemia Research is an international journal which brings comprehensive and current information to all health care professionals involved in basic and (or) applied clinical research in leukemias, lymphomas, multiple myeloma and other hematologic malignancies. The editors encourage the submission of articles relevant to normal and leukemic hemopoiesis, biochemistry, cell biology, immunology and molecular biology as well as epidemiologic and clinical studies.

Specifically, of major interest will be articles that encompass the application of oncogenes, growth factors, cell markers, cell cycle and differentiation agents, novel therapeutics and clinical trials in both the acute and chronic leukemias as well as the myelodysplastic syndromes. In addition we solicit selected articles on the rapidly increasing specialty of marrow or stem cell reconstitution after high dose therapy with curative attempt in patients with a wide range of neoplasms.

 

Word count limit does not include the references, acknowledgement document, figures and tables.

Original Articles are full-length research papers which have not been published previously, except in a preliminary form. An Original paper usually does not exceed 3,000 words, longer papers may be considered if relevant, limit of 50 references and no limit for figures and/or tables.

Myeloma Articles are full-length research papers specifically in the field of Myeloma research. They should follow the same format as an Original Article.

Review Articles should be submitted after prior consultation with an Editor. This paper should not exceed 5,000 words but longer papers may be considered if relevant, limit of 100 references and no limit for figures and/or tables.

Commentaries are longer contributions than Editorials and should be submitted after prior consultation with an Editor. Commentaries do not have abstracts and should not exceed 1,500 words, although longer papers may be considered if relevant, limit of 25 references and no limit for figures and/or tables.

Editorials should be submitted after prior consultation with an Editor. Editorials do not have abstracts and should not exceed 1,000 words, limit of 5 references and optional 1-2 figures and/or tables.

Comments on Published Papers are comments on a prior published paper. Mention the title in both the Cover Letter and the References. This paper does not have an abstract and should not exceed 1,500 words; limit 3 references and optional 1-2 figures and/or tables.

Meeting Reports are free reports on one or several sessions of Congress, Workshops or Symposia (also closed ones), signed by the author(s) whose name appears in the List of Contents. Indicate complete information on the meeting covered, including programme. This paper should not exceed 3,000 words, limit 8 references and no limit on figures and/or tables.

Book Reviews do not have an abstract and should not exceed 1,000 words; limit 3 references.

Open Forum concerns hypotheses, models or experiments which authors wish to see performed but cannot perform themselves. Comments made under this heading engage only the authors and not the Journal, and publication will be at the discretion of the Editor. This paper should not exceed 1,500 words, limit 5 references and optional 1-2 figures and/or tables.

 

Authors may send queries concerning the submission process, manuscript status, or journal procedures to the Editorial Office (e-mail: LR@elsevier.com).

 

Submission checklist

 

You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details.

 

Ensure that the following items are present:

 

One author has been designated as the corresponding author with contact details:

E-mail address

Full postal address

 

All necessary files have been uploaded:

Manuscript:

Include keywords

All figures (include relevant captions)

All tables (including titles, description, footnotes)

Ensure all figure and table citations in the text match the files provided

Indicate clearly if color should be used for any figures in print

Graphical Abstracts / Highlights files (where applicable)

Supplemental files (where applicable)

 

Further considerations

Manuscript has been 'spell checked' and 'grammar checked'

All references mentioned in the Reference List are cited in the text, and vice versa

Permission has been obtained for use of copyrighted material from other sources (including the Internet)

Relevant declarations of interest have been made

Journal policies detailed in this guide have been reviewed

Referee suggestions and contact details provided, based on journal requirements

 

Submission

 

Our online submission system guides you stepwise through the process of entering your article details and uploading your files. The system converts your article files to a single PDF file used in the peer-review process. Editable files (e.g., Word, LaTeX) are required to typeset your article for final publication. All correspondence, including notification of the Editor's decision and requests for revision, is sent by e-mail.

 

Submit your article

Please submit your article via http://ees.elsevier.com/lr/

 

编辑部

Rasika Paul James

Phone +91 44 4299 4784

Email Rasika Paul James

 

主编

Eric Feldman

Seattle Genetics, 21823 30th Drive Southeast, Bothell, Washington, 98021, USA

 

副主编

Tim Hughes

Dept. of Haematology, Royal Adelaide Hospital, PO Box 14 Rundle Mall, Adelaide, 5000, South Australia, Australia

Karl-Anton Kreuzer

Dept. of Internal Medicine, Universität zu Köln, Kerpener Strasse 62, 50937, Cologne, Germany

 

编辑

Editorial Board Members

I. Abraham

Tucson, Arizona, USA

A.M. Almeida

Portugal

D. Alpar

Vienna, Austria

E. Atallah

Milwaukee, Wisconsin, USA

H. Auner

London, England, UK

J. Bennett

New York, New York, USA

E. Berman

New York, New York, USA

M. Breccia

Rome, Italy

F. Caligaris-Cappio

Milano, Italy

J. Castillo

Boston, Massachusetts, USA

H. Chang

Toronto, Ontario, Canada

D. Deeren

Roeselare, Belgium

F. Di Raimondo

Catania, Italy

M. D. Diamantidis

Larissa, Greece

S.G. Fisher, MS, PhD

Philadelphia, Pennsylvania, USA

F. Forghieri

Modena, Italy

R.P. Gale

London, UK

S. Grant

Richmond, Virginia, USA

N. Guriec

Brest, France

T. Haferlach

Munich, Germany

H.T. Hassan

Paisley, Scotland, UK

D. Hiwase

Adelaide, South Australia, Australia

T. Hu

Newark, New Jersey, USA

A. Iqbal

Rochester, New York, USA


投稿问答最小化  关闭